We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAL icon
1876
Amalgamated Financial
AMAL
$1.53B
$25.3K ﹤0.01%
1,098
+236
+27% +$5.72K
OSUR icon
1877
OraSure Technologies
OSUR
$277M
$25.2K ﹤0.01%
5,234
IVR icon
1878
Invesco Mortgage Capital
IVR
$805M
$25.2K ﹤0.01%
1,979
USER
1879
DELISTED
UserTesting, Inc.
USER
$25.2K ﹤0.01%
+3,354
New +$21.5K
SGMO
1880
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$25.2K ﹤0.01%
8,015
+1,928
+32% +$7.48K
TRC icon
1881
Tejon Ranch
TRC
$443M
$25.2K ﹤0.01%
1,335
ESPR
1882
DELISTED
Esperion Therapeutics
ESPR
$25.1K ﹤0.01%
4,032
HIFS icon
1883
Hingham Institution for Saving
HIFS
$686M
$25.1K ﹤0.01%
91
+14
+18% +$3.69K
IBRX icon
1884
ImmunityBio
IBRX
$8.11B
$25.1K ﹤0.01%
4,953
AAN
1885
DELISTED
The Aaron's Company Inc
AAN
$25.1K ﹤0.01%
2,100
EWTX icon
1886
Edgewise Therapeutics
EWTX
$4.69B
$25.1K ﹤0.01%
2,804
RUSHB icon
1887
Rush Enterprises Class B
RUSHB
$9.37B
$25K ﹤0.01%
668
FMNB icon
1888
Farmers National Banc Corp
FMNB
$970M
$25K ﹤0.01%
1,773
CSV icon
1889
Carriage Services
CSV
$555M
$25K ﹤0.01%
909
EZPW icon
1890
Ezcorp Inc
EZPW
$1.76B
$25K ﹤0.01%
3,071
DXLG icon
1891
Destination XL Group
DXLG
$33.2M
$25K ﹤0.01%
3,701
+1,865
+102% +$12K
FORR icon
1892
Forrester Research
FORR
$224M
$25K ﹤0.01%
698
BZH icon
1893
Beazer Homes USA
BZH
$874M
$24.9K ﹤0.01%
1,955
CDRE icon
1894
Cadre Holdings
CDRE
$1.45B
$24.9K ﹤0.01%
1,235
+124
+11% +$3.2K
MGNX icon
1895
MacroGenics
MGNX
$259M
$24.8K ﹤0.01%
3,691
REPX icon
1896
Riley Exploration Permian
REPX
$786M
$24.7K ﹤0.01%
839
BHR
1897
Braemar Hotels & Resorts
BHR
$139M
$24.7K ﹤0.01%
6,007
-9
-0.1% -$37
TPIC
1898
DELISTED
TPI Composites
TPIC
$24.7K ﹤0.01%
2,434
PSFE icon
1899
Paysafe
PSFE
$405M
$24.6K ﹤0.01%
1,773
ZUMZ icon
1900
Zumiez
ZUMZ
$319M
$24.6K ﹤0.01%
1,130

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.